Ani Pharmaceuticals ANIP
NASDAQ ANIP
$70.96 -0.48 (-0.67%)
As of: Nov 16, 2026 · 1:59 PM EST

Ani Pharmaceuticals (ANIP) Revenue (2009 - 2026)

Updated

Ani Pharmaceuticals (ANIP) recorded Revenue of $290.78 million in Q3 2026, up 27.6% from $227.81 million a year earlier and up 9.3% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Revenue (2009 - 2026) Analysis & Trends

On a TTM basis, Ani Pharmaceuticals' Revenue came in at $1.04 billion as of Sep 30, 2026, up 25.9% year-over-year; for FY2025, it came in at $883.37 million, up 43.8% from FY2024.

  • Annual Revenue has increased for 13 straight years, with a five-year compound annual growth rate of 33.5% (FY2020 to FY2025).
  • Across earlier years, Revenue came in at $614.38 million in FY2024 (+26.2%), $486.82 million in FY2023 (+53.9%), $316.39 million in FY2022 (+46.4%) and $216.14 million in FY2021 (+3.7%).
  • The Q3 2026 figure is the highest quarterly Revenue in data going back to Q1 2009.
  • On a year-over-year basis, Revenue has increased for 20 consecutive quarters, with growth averaging 37.3% over the last eight quarters.
  • The year-over-year growth in Revenue has ranged between 6.4% (Q4 2021) and 65.6% (Q1 2023) over the last five years.
  • Per Business Quant, the preceding three quarters came in at $266.04 million (Q2 2026), $237.46 million (Q1 2026) and $247.06 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,286.98 Bn 1,260.60 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 685.09 Bn 604.95 Bn 17.30 Bn 25.40 Bn
3 AbbVie 523.41 Bn 491.42 Bn 13.12 Bn 17.40 Bn
4 Merck 361.33 Bn 324.27 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 312.92 Bn 286.15 Bn - -
6 Astrazeneca 286.64 Bn 260.16 Bn 13.26 Bn 15.07 Bn
7 Amgen 252.19 Bn 203.84 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 209.51 Bn 184.62 Bn 6.73 Bn 8.30 Bn
9 Pfizer 165.21 Bn 112.57 Bn 12.56 Bn 16.58 Bn
10 Ani Pharmaceuticals 1.51 Bn 127.47 Mn 179.25 Mn 290.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 290.78 Mn
Jun 30, 2026 266.04 Mn
Mar 31, 2026 237.46 Mn
Dec 31, 2025 247.06 Mn
Sep 30, 2025 227.81 Mn
Jun 30, 2025 211.37 Mn
Mar 31, 2025 197.12 Mn
Dec 31, 2024 190.57 Mn
Sep 30, 2024 148.33 Mn
Jun 30, 2024 138.04 Mn
Mar 31, 2024 137.43 Mn
Dec 31, 2023 131.65 Mn
Sep 30, 2023 131.83 Mn
Jun 30, 2023 116.55 Mn
Mar 31, 2023 106.79 Mn
Dec 31, 2022 94.23 Mn
Sep 30, 2022 83.82 Mn
Jun 30, 2022 73.86 Mn
Mar 31, 2022 64.48 Mn
Dec 31, 2021 60.93 Mn
API Access

Ani Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ANIP&period=max&api_key=YOUR_API_KEY